These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 11217907
1. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Loppow D, Schleiss MB, Kanniess F, Taube C, Jörres RA, Magnussen H. Respir Med; 2001 Feb; 95(2):115-21. PubMed ID: 11217907 [Abstract] [Full Text] [Related]
2. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. Chaudhuri R, McMahon AD, Thomson LJ, MacLeod KJ, McSharry CP, Livingston E, McKay A, Thomson NC. J Allergy Clin Immunol; 2004 Jun; 113(6):1063-70. PubMed ID: 15208586 [Abstract] [Full Text] [Related]
3. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Hothersall EJ, Chaudhuri R, McSharry C, Donnelly I, Lafferty J, McMahon AD, Weir CJ, Meiklejohn J, Sattar N, McInnes I, Wood S, Thomson NC. Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458 [Abstract] [Full Text] [Related]
4. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103 [Abstract] [Full Text] [Related]
6. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Basyigit I, Yildiz F, Ozkara SK, Boyaci H, Ilgazli A. Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060 [Abstract] [Full Text] [Related]
7. Exhaled nitric oxide in chronic obstructive pulmonary disease. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):998-1002. PubMed ID: 9517624 [Abstract] [Full Text] [Related]
8. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD. Thompson WH, Carvalho P, Souza JP, Charan NB. Lung; 2002 Mar; 180(4):191-201. PubMed ID: 12391509 [Abstract] [Full Text] [Related]
9. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC. Am J Respir Crit Care Med; 2002 Jun 15; 165(12):1592-6. PubMed ID: 12070058 [Abstract] [Full Text] [Related]
10. Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids. Kelly MM, Leigh R, Jayaram L, Goldsmith CH, Parameswaran K, Hargreave FE. J Allergy Clin Immunol; 2006 May 15; 117(5):989-94. PubMed ID: 16675323 [Abstract] [Full Text] [Related]
11. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. J Allergy Clin Immunol; 2000 Oct 15; 106(4):638-44. PubMed ID: 11031333 [Abstract] [Full Text] [Related]
12. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma. Mehta V, Stokes JR, Berro A, Romero FA, Casale TB. Ann Allergy Asthma Immunol; 2009 Jul 15; 103(1):31-7. PubMed ID: 19663124 [Abstract] [Full Text] [Related]
13. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. N Engl J Med; 2005 May 26; 352(21):2163-73. PubMed ID: 15914548 [Abstract] [Full Text] [Related]
14. Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma. Ehrs PO, Sundblad BM, Larsson K. Clin Respir J; 2010 Jan 26; 4(1):51-8. PubMed ID: 20298418 [Abstract] [Full Text] [Related]
15. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma. Koopmans JG, Lutter R, Jansen HM, van der Zee JS. Thorax; 2006 Apr 26; 61(4):306-12. PubMed ID: 16449264 [Abstract] [Full Text] [Related]
16. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma. van den Toorn LM, Prins JB, de Jongste JC, Leman K, Mulder PG, Hoogsteden HC, Overbeek SE. Respir Med; 2005 Jun 26; 99(6):779-87. PubMed ID: 15878496 [Abstract] [Full Text] [Related]
17. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma. Norris V, Choong L, Tran D, Corden Z, Boyce M, Arshad H, Holgate S, O'Connor B, Millet S, Miller B, Rohatagi S, Kirkesseli S. J Allergy Clin Immunol; 2005 Oct 26; 116(4):761-7. PubMed ID: 16210048 [Abstract] [Full Text] [Related]
18. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Brightling CE, McKenna S, Hargadon B, Birring S, Green R, Siva R, Berry M, Parker D, Monteiro W, Pavord ID, Bradding P. Thorax; 2005 Mar 26; 60(3):193-8. PubMed ID: 15741434 [Abstract] [Full Text] [Related]
19. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study. Kunisaki KM, Rice KL, Janoff EN, Rector TS, Niewoehner DE. Ther Adv Respir Dis; 2008 Apr 26; 2(2):55-64. PubMed ID: 19124359 [Abstract] [Full Text] [Related]
20. Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice. Quaedvlieg V, Sele J, Henket M, Louis R. Clin Exp Allergy; 2009 Dec 26; 39(12):1822-9. PubMed ID: 19817755 [Abstract] [Full Text] [Related] Page: [Next] [New Search]